Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-002508-15Phase 3Completed
Phase 3, randomised, double-blind trial of cadazolid in Clostridioides difficile colitis (CDI) (2 arms), sponsored by Actelion Pharmaceuticals Ltd. Primary endpoint: Clinical Cure. Started Dec 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-002508-15.